Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial. - Rousel, Jannik; Saghari, Mahdi; Pagan, Lisa; Nădăban, Andreea; Gambrah, Tom; Theelen, Bart; de Kam, Marieke L.; Haakman, Jorine; van der Wall, Hein E. C.; Feiss, Gary L.; Niemeyer-van der Kolk, Tessa; Burggraaf, Jacobus; et al. (International Journal of Molecular Sciences, 2023)